Toll Free: 1-888-928-9744

Antiobesity Drugs Global Market Report 2020 Including: 1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs 2) By Type: Prescription Drugs (Rx), OTC Drugs 3) By Medication: Monotherapies, Polytherapies Covering: F. Hoffmann-La Roche AG,, GlaxoSmithKline PLC,, Boehringer Ingelheim GmbH,, Pfizer Inc.,, Merck & Co. Inc.,

Published: Nov, 2019 | Pages: 200 | Publisher: The Business Research Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Antiobesity Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiobesity drugs market.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. 
• Create regional and country strategies on the basis of local data and analysis. 
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market. 
• Understand customers based on the latest market research findings. 
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description: 
Where is the largest and fastest growing market for the antiobesity drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antiobesity Drugs Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
• The Market Characteristics section of the report defines and explains the market.
• The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market Segmentations break down market into sub markets.
• The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. 
• Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered:  1) By Drug Class: Peripherally acting anti obesity drugs, Centrally acting anti obesity drugs 2) By Type:  Prescription Drugs (Rx), OTC Drugs 3) By Medication: Monotherapies, Polytherapies

Companies Mentioned: F. Hoffmann-La Roche AG, , GlaxoSmithKline PLC, , Boehringer Ingelheim GmbH, , Pfizer Inc.,,  Merck & Co. Inc.,

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
 Table of Contents

1. Executive Summary 2. Anti-obesity Drugs Market Characteristics 3. Anti-obesity Drugs Market Size And Growth 3.1. Global Anti-obesity Drugs Historic Market, 2015 - 2019, $ Billion 3.1.1. Drivers Of The Market 3.1.2. Restraints On The Market 3.2. Global Anti-obesity Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion 3.2.1. Drivers Of The Market 3.2.2. Restraints On the Market 4. Anti-obesity Drugs Market Segmentation 4.1. Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Peripherally acting anti obesity drugs Centrally acting anti obesity drugs 4.2. Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Prescription Drugs (Rx) OTC Drugs 4.3. Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Monotherapies Polytherapies 5. Anti-obesity Drugs Market Regional And Country Analysis 5.1. Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 5.2. Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6. Asia-Pacific Anti-obesity Drugs Market 6.1. Asia-Pacific Anti-obesity Drugs Market Overview 6.2. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6.3. Asia-Pacific Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 7. China Anti-obesity Drugs Market 7.1. China Anti-obesity Drugs Market Overview 7.2. China Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 7.3. China Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 8. India Anti-obesity Drugs Market 8.1. India Anti-obesity Drugs Market Overview 8.2. India Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 8.3. India Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9. Japan Anti-obesity Drugs Market 9.1. Japan Anti-obesity Drugs Market Overview 9.2. Japan Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9.3. Japan Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10. Australia Anti-obesity Drugs Market 10.1. Australia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10.2. Australia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11. Indonesia Anti-obesity Drugs Market 11.1. Indonesia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11.2. Indonesia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12. South Korea Anti-obesity Drugs Market 12.1. South Korea Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12.2. South Korea Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13. Western Europe Anti-obesity Drugs Market 13.1. Western Europe Anti-obesity Drugs Market Overview 13.2. Western Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13.3. Western Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14. UK Anti-obesity Drugs Market 14.1. UK Anti-obesity Drugs Market Overview 14.2. UK Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14.3. UK Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15. Germany Anti-obesity Drugs Market 15.1. Germany Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15.2. Germany Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16. France Anti-obesity Drugs Market 16.4. France Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16.5. France Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17. Eastern Europe Anti-obesity Drugs Market 17.1. Eastern Europe Anti-obesity Drugs Market Overview 17.2. Eastern Europe Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17.3. Eastern Europe Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18. Russia Anti-obesity Drugs Market 18.1. Russia Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18.2. Russia Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19. North America Anti-obesity Drugs Market 19.1. North America Anti-obesity Drugs Market Overview 19.2. North America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19.3. North America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20. USA Anti-obesity Drugs Market 20.1. USA Anti-obesity Drugs Market Overview 20.2. USA Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20.3. USA Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21. South America Anti-obesity Drugs Market 21.1. South America Anti-obesity Drugs Market Overview 21.2. South America Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21.3. South America Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22. Brazil Anti-obesity Drugs Market 22.1. Brazil Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22.2. Brazil Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23. Middle East Anti-obesity Drugs Market 23.1. Middle East Anti-obesity Drugs Market Overview 23.2. Middle East Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23.3. Middle East Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24. Africa Anti-obesity Drugs Market 24.1. Africa Anti-obesity Drugs Market Overview 24.2. Africa Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24.3. Africa Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 25. Anti-obesity Drugs Market Competitive Landscape And Company Profiles 25.1. Anti-obesity Drugs Market Competitive Landscape 25.2. Anti-obesity Drugs Market Company Profiles 25.2.1. F. Hoffmann-La Roche AG, 25.2.1.1. Overview 25.2.1.2. Products and Services 25.2.1.3. Strategy 25.2.1.4. Financial Performance 25.2.2. GlaxoSmithKline PLC, 25.2.2.1. Overview 25.2.2.2. Products and Services 25.2.2.3. Strategy 25.2.2.4. Financial Performance 25.2.3. Boehringer Ingelheim GmbH, 25.2.3.1. Overview 25.2.3.2. Products and Services 25.2.3.3. Strategy 25.2.3.4. Financial Performance 25.2.4. Pfizer Inc., 25.2.4.1. Overview 25.2.4.2. Products and Services 25.2.4.3. Strategy 25.2.4.4. Financial Performance 25.2.5. Merck & Co. Inc., 25.2.5.1. Overview 25.2.5.2. Products and Services 25.2.5.3. Strategy 25.2.5.4. Financial Performance 26. Key Mergers And Acquisitions In The Anti-obesity Drugs Market 27. Anti-obesity Drugs Market Trends And Strategies 28. Product Pipeline Analysis 29. Anti-obesity Drugs Market Future Outlook and Potential Analysis 30. Appendix 30.1. Abbreviations 30.2. Currencies 30.3. Research Inquiries 30.4. The Business Research Company 30.5. Copyright And Disclaimer
List of Tables

Table 1: Global Historic Market Growth, 2015-2019, $ Billion Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion Table 3: Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 4: Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 5: Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 6: Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 7: Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 8: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 9: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 10: China, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 11: China, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 12: India, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 13: India, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 14: Japan, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 15: Japan, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 16: Australia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 17: Australia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 18: Indonesia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 19: Indonesia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 20: South Korea, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 21: South Korea, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 22: Western Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 23: Western Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 24: UK, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 25: UK, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 26: Germany, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 27: Germany, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 28: France, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 29: France, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 30: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 31: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 32: Russia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 33: Russia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 34: North America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 35: North America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 36: USA, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 37: USA, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 38: South America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 39: South America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 40: Brazil, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 41: Brazil, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 42: Middle East, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 43: Middle East, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 44: Africa, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 45: Africa, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 46: F. Hoffmann-La Roche AG, Financial Performance Table 47: GlaxoSmithKline PLC, Financial Performance Table 48: Boehringer Ingelheim GmbH, Financial Performance Table 49: Pfizer Inc., Financial Performance Table 50: Merck & Co. Inc., Financial Performance


List of Figures

Figure 1: Global Historic Market Growth, 2015-2019, $ Billion Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion Figure 3: Global Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 4: Global Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 5: Global Anti-obesity Drugs Market, Segmentation By Medication, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 6: Global Anti-obesity Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 7: Global Anti-obesity Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 8: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 9: Asia-Pacific, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 10: China, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 11: China, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 12: India, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 13: India, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 14: Japan, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 15: Japan, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 16: Australia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 17: Australia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 18: Indonesia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 19: Indonesia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 20: South Korea, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 21: South Korea, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 22: Western Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 23: Western Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 24: UK, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 25: UK, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 26: Germany, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 27: Germany, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 28: France, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 29: France, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 30: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 31: Eastern Europe, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 32: Russia, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 33: Russia, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 34: North America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 35: North America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 36: USA, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 37: USA, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 38: South America, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 39: South America, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 40: Brazil, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 41: Brazil, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 42: Middle East, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 43: Middle East, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 44: Africa, Anti-obesity Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 45: Africa, Anti-obesity Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 46: F. Hoffmann-La Roche AG, Financial Performance Figure 47: GlaxoSmithKline PLC, Financial Performance Figure 48: Boehringer Ingelheim GmbH, Financial Performance Figure 49: Pfizer Inc., Financial Performance Figure 50: Merck & Co. Inc., Financial Performance

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $4000
Multi User - US $6000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify